« Back
Home /
Ezabenlimab Biosimilar(Anti-PDCD1 / PD-1 / CD279 Reference Antibody)

Ezabenlimab Biosimilar(Anti-PDCD1 / PD-1 / CD279 Reference Antibody)

Item no.	DCC-A423-1mg
Manufacturer	DCChemicals
CASRN	2249882-54-8
Amount	1 mg
Quantity options	100 mg 10 mg 1 mg 5 mg
Specific against	other
Available
Manufacturer - Applications	Ezabenlimab (BI-754091) is an anti-PD-1 mAb with binding constant Kd value of 6 nM (CHO cells). Ezabenlimab blocks the interaction of PD-1 with PD-L1 and PD-L2. Ezabenlimab increases interferon-γ secretion in T cells, and inhibits tumor growth in vivo.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 12/11/2025

Compare

Add to wishlist

Get an offer

Request delivery time